Howard Mcleod serves as Executive at CANCER GENETICS, INC, where they oversee executive responsibilities. Since joining the company, Howard Mcleod has executed 6 insider transactions totaling $2.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 30, 2022 involved receiving (via award) 43,478 shares valued at $0.
Howard Mcleod currently holds 43,927 shares of CANCER GENETICS, INC (CGIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Howard Mcleod has been a net buyer of CGIX stock. They have purchased $2.7K and sold $0 worth of shares.
Howard Mcleod's most recent insider trade was on Mar 30, 2022, when they sold 43,478 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 7, 2017 | CGIX | $0 | Award | 2,500 | $N/A | Discretionary |
| Oct 11, 2016 | CGIX | $0 | Award | 2,500 | $N/A | Discretionary |
| Mar 17, 2016 | CGIX | $2.7K | Purchase | 1,000 | $2.71 | Discretionary |
| May 14, 2015 | CGIX | $0 | Award | 5,000 | $N/A | Discretionary |